Literature DB >> 25543267

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.

Estíbaliz Loza1, Cristina Lajas, Jose Luis Andreu, Alejandro Balsa, Isidoro González-Álvaro, Oscar Illera, Juan Ángel Jover, Isabel Mateo, Javier Orte, Javier Rivera, José Manuel Rodríguez Heredia, Fredeswinda Romero, Juan Antonio Martínez-López, Ana María Ortiz, Esther Toledano, Virginia Villaverde, Loreto Carmona, Santos Castañeda.   

Abstract

The objective of the study was to develop evidence-based and practical recommendations for the detection and management of comorbidity in patients with rheumatoid arthritis (RA) in daily practice. We used a modified RAND/UCLA methodology and systematic review (SR). The process map and specific recommendations, based on the SR, were established in discussion groups. A two round Delphi survey permitted (1) to prioritize the recommendations, (2) to refine them, and (3) to evaluate their agreement by a large group of users. The recommendations cover: (1) which comorbidities should be investigated in clinical practice at the first and following visits (including treatments, risk factors and patient's features that might interfere with RA management); (2) how and when should comorbidities and risk factors be investigated; (3) how to manage specific comorbidities, related or non-related to RA, including major adverse events of RA treatment, and to promote health (general and musculoskeletal health); and (4) specific recommendations to assure an integral care approach for RA patients with any comorbidity, such as health care models for chronic inflammatory patients, early arthritis units, relationships with primary care, specialized nursing care, and self-management. These recommendations are intended to guide rheumatologists, patients, and other stakeholders, on the early diagnosis and management of comorbidity in RA, in order to improve disease outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25543267     DOI: 10.1007/s00296-014-3196-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  80 in total

1.  Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

Authors:  M C van der Goes; J W G Jacobs; M Boers; T Andrews; M A M Blom-Bakkers; F Buttgereit; N Caeyers; M Cutolo; J A P Da Silva; L Guillevin; J R Kirwan; J Rovensky; G Severijns; S Webber; R Westhovens; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2010-08-06       Impact factor: 19.103

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

Review 3.  Health behaviour change interventions for the promotion of physical activity in rheumatoid arthritis: a systematic review.

Authors:  Fiona Cramp; John Berry; Matthew Gardiner; Felicity Smith; Daniel Stephens
Journal:  Musculoskeletal Care       Date:  2013-05-07

4.  Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register.

Authors:  G Haugeberg; T Uhlig; J A Falch; J I Halse; T K Kvien
Journal:  Arthritis Rheum       Date:  2000-12

Review 5.  Comorbidities in rheumatoid arthritis.

Authors:  Kaleb Michaud; Frederick Wolfe
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-10       Impact factor: 4.098

6.  Evaluation of sexual dysfunction in women with rheumatoid arthritis: a controlled study.

Authors:  Halim Yilmaz; Halime Almula Demir Polat; Sema Dereli Yilmaz; Gulten Erkin; Sami Kucuksen; Ali Salli; Hatice Ugurlu
Journal:  J Sex Med       Date:  2012-08-20       Impact factor: 3.802

7.  Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis.

Authors:  Greet Esselens; René Westhovens; Patrick Verschueren
Journal:  Musculoskeletal Care       Date:  2009-03

Review 8.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

9.  Sexual dysfunction among patients with arthritis.

Authors:  D J Blake; R Maisiak; A Koplan; G S Alarcón; S Brown
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

Review 10.  Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Authors:  Beverley Shea; Michael V Swinden; Elizabeth Tanjong Ghogomu; Zulma Ortiz; Wanruchada Katchamart; Tamara Rader; Claire Bombardier; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
View more
  9 in total

Review 1.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

2.  Comparison of the Charlson Comorbidity Index derived from self-report and medical record review in Asian patients with rheumatic diseases.

Authors:  Xinyi Ng; Andrea Hsiu Ling Low; Julian Thumboo
Journal:  Rheumatol Int       Date:  2015-06-10       Impact factor: 2.631

Review 3.  [Characteristics of pharmacotherapy in older patients with rheumatism].

Authors:  H-J Lakomek; Christian Schulz
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

4.  Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.

Authors:  Stefan Schreiber; Jean-Frederic Colombel; Brian G Feagan; Kristian Reich; Atul A Deodhar; Iain B McInnes; Brian Porter; Ayan Das Gupta; Luminita Pricop; Todd Fox
Journal:  Ann Rheum Dis       Date:  2019-01-23       Impact factor: 19.103

5.  Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study.

Authors:  Premarani Sinnathurai; Alexandra Capon; Rachelle Buchbinder; Vibhasha Chand; Lyndall Henderson; Marissa Lassere; Lyn March
Journal:  BMC Rheumatol       Date:  2018-09-06

Review 6.  Management of Fibrosing Interstitial Lung Diseases.

Authors:  Toby M Maher; Wim Wuyts
Journal:  Adv Ther       Date:  2019-05-22       Impact factor: 3.845

Review 7.  Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.

Authors:  Kuang-Hui Yu; Hsin-Hua Chen; Tien-Tsai Cheng; Yeong-Jian Jan; Meng-Yu Weng; Yeong-Jang Lin; Hung-An Chen; Jui-Tseng Cheng; Kuang-Yung Huang; Ko-Jen Li; Yu-Jih Su; Pui-Ying Leong; Wen-Chan Tsai; Joung-Liang Lan; Der-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

Review 8.  The challenging interplay between rheumatoid arthritis, ageing and comorbidities.

Authors:  Marloes van Onna; Annelies Boonen
Journal:  BMC Musculoskelet Disord       Date:  2016-04-26       Impact factor: 2.362

9.  Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study.

Authors:  Javier Rivera; Miguel A Vallejo
Journal:  Rheumatol Int       Date:  2016-09-23       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.